Full-Time

Head of Platform Technology

Confirmed live in the last 24 hours

Deep Genomics

Deep Genomics

51-200 employees

AI-driven drug discovery and development

AI & Machine Learning
Biotechnology

Expert

Cambridge, MA, USA

Position requires onsite presence in Cambridge, MA.

Category
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Machine Learning
Data Analysis
Requirements
  • PhD in biological sciences with 15+ years of post-graduate experience in relevant roles (or equivalent) leveraging genomics technology in early stage drug development.
  • 8+ years building, managing, and leading teams to meet goals of the organization, partners, and patients.
  • A creative thinker with a “platform attitude” and direct experience developing and executing high-quality cell profiling assays and screens using various technologies in an advanced data and computing environment.
  • Experience with quantitative analysis of on-/off-target effects and cell penetrance as applied to genetic medicines including, ASOs, gene editing, & gene therapy.
  • Experience with automation and employing analytical, computational, and statistical methodologies to enhance development workflows.
  • Proficiency in multiple of the following: phenotypic assays, gene editing, automation, high throughput qPCR/ddPCR, high-content imaging, and -omics technologies.
  • Deep molecular biology expertise with experience in state-of-the art methods for large scale library production & screening using barcoded technologies including MPRAs, Pertub-seq, and other similar technologies.
  • Proven ability to work independently and cross-functionally with highly skilled teams in a fast-paced, entrepreneurial, and technical environment.
  • Strong managerial qualities, including a strategic and scientifically oriented mindset, attention to detail, strong organizational skills, emotional intelligence, credibility, integrity, creativity, and a willingness to have ideas challenged by team members and to challenge them.
  • Ability to organize and communicate complex data sets in a clear and concise manner to key stakeholders from diverse backgrounds.
  • Prior experience working with or leading collaborations with external biotechnology, academic, and contract research organizations.
Responsibilities
  • Work cross-functionally with internal stakeholders to define and execute a strategy that grows the AI platform to unlock new genetic medicines.
  • Build and lead a team of scientists dedicated to the development and implementation of sequencing, molecular profiling, and assay technologies across single-molecule and cellular assays to broad -omics applications.
  • In collaboration with the Machine Learning team, identify opportunities, set strategy, and lead execution of projects for generation of large scale multi-omics data in disease-relevant contexts for model training validation.
  • Build an environment & culture focused on generating high quality proprietary data, and create a tight feedback loop between modeling & experiment through close collaboration with the machine learning, Target ID, and Platform Technology teams.
  • Work with the computational biology and engineering teams to develop analytical methods and ensure efficient data capture through the ELN system and Deep Genomics Nexus platform.
  • Contribute to key corporate initiatives by supporting business development activities as well as identifying opportunities to access relevant data sets through strategic partnerships.
  • Demonstrate strong leadership, personal accountability and interpersonal skills, and capability for mentoring (direct reports & others).
  • Present data and strategy to scientists and management in internal and external venues and publish in peer-reviewed journals as appropriate.
Desired Qualifications
  • Background in a scientific field involving quantitative modeling, such as biophysics or computational chemistry.
  • Direct experience with building novel screening pipelines using single c.
  • Experience with additional high throughput methods including quantitative imaging, proteomics, and functional genomics is highly beneficial.
  • Familiarity with oligonucleotide chemistry and analytic methods would be beneficial.
  • Strong computational background or demonstrated ability to interface with computational biology teams to develop computational pipelines for analysis of genomics data.
  • Experience with multi-site project management and team leadership.

Deep Genomics focuses on drug development in the biotechnology sector by utilizing artificial intelligence to explore RNA biology and discover potential therapies for genetic conditions. The main product is the AI Workbench, a tool that analyzes data to predict and identify new drug targets. This company distinguishes itself from competitors by its specific focus on RNA splicing and the continuous improvement of its AI Workbench, which has evolved through multiple versions to enhance its capabilities in targeting complex genetic diseases. The goal of Deep Genomics is to accelerate the drug discovery process and provide better treatment options for patients suffering from genetic disorders.

Company Stage

Series C

Total Funding

$230.3M

Headquarters

Toronto, Canada

Founded

2014

Growth & Insights
Headcount

6 month growth

1%

1 year growth

1%

2 year growth

-1%
Simplify Jobs

Simplify's Take

What believers are saying

  • AI integration with CRISPR allows precise gene editing and therapeutic development.
  • AI-driven platforms optimize clinical trial designs, reducing costs and time to market.
  • AI identifies novel biomarkers, expanding target discovery capabilities.

What critics are saying

  • Increased competition from companies like Insitro and Recursion Pharmaceuticals.
  • Rapid technological advancements may render current AI Workbench obsolete.
  • Ethical concerns and regulatory scrutiny could delay product development timelines.

What makes Deep Genomics unique

  • Deep Genomics uses AI to unravel RNA biology for drug development.
  • The AI Workbench identifies novel drug targets and therapeutic candidates.
  • BigRNA model advances RNA disease mechanism discovery and candidate therapeutics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Professional Development Budget